Business Wire

MakeMeReach Becomes a Snapchat Partner

Share

MakeMeReach has hit today a new milestone: being approved as a Snapchat Partner. The French social ad-tech company confirms its growth: as an long-term ad partner of Facebook, Twitter and Instagram, MakeMeReach is now convinced that Snapchat ads are going to open new possibilities to its +4000 clients worldwide.

We are thrilled to announce that we have been vetted as an official Snapchat Partner! From today, the new integration with the MakeMeReach platform will allow all our clients to run campaigns on Snapchat and to benefit from the expertise of our team on this very fast growing social media platform. This recognition by Snap Inc. also marks a new milestone in the MakeMeReach story. After integration with Facebook, Instagram and Twitter,the new partnership completes our offering as the ultimate social ad-tech solution provider.”

Pierre-François Chiron & Pierre-Lou Dominjon
Co-Founders of MakeMeReach

Snapchat, a must-have for video advertisers

Over 160 million people use Snapchat every day to Snap with family, watch Stories from friends, see events from around the world, and explore expertly-curated content from top publishers. Snap ads are an up to 10-second, verticaland full-screen video, frequently played with sound on, which can also include the option to swipe up into an attachment.

Ads on Snapchat come in many shapes and sizes to fit marketers’ goals: video view, mobile app-Install, awareness, and web traffic.

Using a Snapchat Partner like MakeMeReach is a way for advertisers to launch campaigns with any size budget, and also to manage the ads directly from a partner platform. Advertisers will be able to create, optimize and analyze their Snap ads campaigns on their own with the MakeMeReach platform.

MakeMeReach conducted a survey on the perception of Snapchat ads: results are very promising for advertisers!

To help its customers understand why and how Snapchat ads are new opportunities for them, MakeMeReach worked with IFOP (The Institut français d'opinion publique - a leading international polling and market research firm), to ask users about their habits and perception of ads on Snapchat.

Among other findings, this survey reveals that 55% of Snapchat users remember seeing an ad on Snapchat. This percentage goes up for Millennials as 74% of 18-24 years olds can recall ads on Snapchat. Advertisers who know how hard it is to get ad recall will definitely be impressed by these high metrics, especially for the Millennial target whose attention is particularly hard to catch.

A very large majority (61%) likes watching ads on Snapchat. 30% even watch the ads until the end, which is higher than the average on other networks

The positive perception of Snapchat ads is definitely due to the ad format itself: users have the ability to swipe the ad, and thus, they consider the Snapchat ad less intrusive than other ad formats.
69% think that having the choice to watch the ad makes the Snapchat ad more appealing than other social network’ ads. That’s a real asset for Snapchat!

Finally, the survey showed a huge impact of Snapchat ads on purchase intention: 71% of users say that an ad on Snapchat can influence their desire to buy the product.

*Source: IFOP for MakeMeReach (April 2017)

This survey has been conducted by the French Institute IFOP using a representative sample of the French population; consisting of 1600 people who are at least 18 years old.
This representative sample is guaranteed by the method of quotas (gender, age, profession of head of household) and categorization by region and type of agglomeration. CAWI (Computer Assisted Web Interviewing) interviews were conducted online through self-administered questionnaires from the 3rd to the 5th of Apr 2017.

About MakeMeReach

Founded in 2009 by Pierre-François Chiron and Pierre Lou Dominjon, MakeMeReach is a fast-growing social ad tech company, empowerING agencies (Dentsu-Aegis, GroupM, OMD...) and advertisers (Birchbox, FlyDubai, Iberia, Happn, Privalia...) to elevate their campaigns on Facebook, Twitter, Instagram and Snapchat, at scale. MakeMeReach leverages a cutting-edge platform that automates and optimizes all social ad campaigns in one place, providing a team of performance marketing experts who maximize ad efficiency. Intuitive tools and leading expertise have led to success of thousands of customers worldwide. MakeMeReach is vetted by Facebook, Twitter, Instagram and Snapchat as an Official Partner.
With 50+ employees,MakeMeReach is the leading social ad partner in many countries, and is part of Perion network Ltd. (NASDAQ :PERI) since 2015.

About Perion Network Ltd.

Perion is a global technology company that delivers advertising solutions to brands and publishers. Perion is committed to providing data-driven execution, from high-impact ad formats to branded search and a unified social and mobile programmatic platform. More information about Perion may be found at www.perion.com, and follow Perion on Twitter @perionnetwork.

For more information about the survey, please contact us: contact@makemereach.com or visit info.makemereach.com/snapchat

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

MakeMeReach (part of Perion network Ltd.)
Anne Tirmont, + 33.6.13.49.75.17
Marketing and Communication Manager
annet@perion.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i

Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release

Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d

The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release

Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release

4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release

Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye